Hemogenyx Pharmaceuticals Competitors and Similar CompaniesClear all

Hemogenyx Pharmaceuticals's competitors and similar companies include LTS Lohmann Therapie-Systeme, Teva Pharmaceuticals, Chaperone Therapeutics and Andromaco.

	Hemogenyx Pharmaceuticals Hemogenyx Pharmaceuticals, formerly Silver Falcon, is a pre-clinical stage biopharmaceutical company.	LTS Lohmann Therapie-Systeme LTS Lohmann Therapie-Systeme develops and manufactures transdermal drug delivery systems for pharmaceutical active substances.	Teva Pharmaceuticals Teva Pharmaceuticals is a global pharmaceutical company.	Chaperone Therapeutics Chaperone Therapeutics is a company developing frontline therapies to address diseases of protein misfolding.	Andromaco Andromaco is a pharmaceutical company.
Founding Date	Founding Date 2013	Founding Date 1984	Founding Date 1901	Founding Date 2009	Founding Date N/A
Type	Type Public	Type Subsidiary	Type Public	Type Private	Type Private
Tags	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy	Tags Healthcare drug development pharma therapy
Locations	Locations London, GB HQ	Locations Andernach, DE HQ Shanghai, CN West Caldwell, US	Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more	Locations Durham, US HQ	Locations CL HQ
Employees	Employees 17	Employees 2941% increase	Employees 33,8928% decrease	Employees 3915% increase	Employees 182
Valuation ($)	Valuation ($) 23.1 m	Valuation ($) N/A	Valuation ($) 20.8 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $16.5b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $8.5b (FY, 2024)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $8.1b (FY, 2024)	Gross profit N/A	Gross profit N/A
Net income	Net income (£6.7m) (FY, 2023)	Net income N/A	Net income ($2b) (FY, 2024)	Net income N/A	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 358m	Total funding raised $ 456.6k	Total funding raised N/A